Evidence map›Paper›PMID 30211192›Full record

ArticleAnnals of translational medicine2018

Prolonged dexmedetomidine infusion in critically ill adult patients: a retrospective analysis of a large clinical database Multiparameter Intelligent Monitoring in Intensive Care III.

Yue Zhao, Huaqiang Zhou, Wulin Tan, Yiyan Song, Zeting Qiu, Si Li, Shaowei Gao, Wenqi Huang

Open access · hybridAbstract read
In one paragraph

Article in Annals of translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yue ZhaoDepartment of Anesthesia, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Huaqiang ZhouZhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
Wulin TanDepartment of Anesthesia, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Yiyan SongZhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
Zeting QiuDepartment of Anesthesia, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Si LiZhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
Shaowei GaoDepartment of Anesthesia, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Wenqi HuangDepartment of Anesthesia, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Sun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is no conclusive evidence for the effects of prolonged infusion of dexmedetomidine in critically ill patients. We aimed to investigate the safety of long-term dexmedetomidine infusion in a large critically ill patients cohort from the Multiparameter Intelligent Monitoring in Intensive Care III (MIMIC-III) database.

methodsWe retrospectively extracted records from MIMIC-III database. Dexmedetomidine administration time was the basis for group. Variables were compared by chi-square tests, and Mann-Whitney U test as appropriate. We used logistic regression model for multivariate analysis. Contour maps were drawn to measure rebound of heart rate (HR) and blood pressure (BP).

resultsWe finally got 1,946 records including 1,368 distinct individuals. Age, body mass index (BMI), length of stay in hospital, accumulated doses of dexmedetomidine and Sequential Organ Failure Assessment (SOFA) score were independent risk factors of in-hospital mortality (P<0.05). But prolonged dexmedetomidine infusion (≥24 h) and abrupt cessation did not increase in-hospital mortality. Furthermore, the rebound of HR and BP was more likely to occur in patients with prolonged infusion of dexmedetomidine.

conclusionsProlonged dexmedetomidine infusion is not related to an increased in-hospital mortality, but it is associated with the rebound effect of HR and BP. Further prospective studies are needed.

Indexed as

DexmedetomidinemortalityMultiparameter Intelligent Monitoring in Intensive Care III database (MIMIC-III database)rebound effect

Identifiers

PMID30211192
PMCPMC6123197
OpenAlexW2887282136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.